Figures & data
Table 1. Top articles in Nanomedicine’s 2020 issues by readershipTable Footnote†
.
Table 2. Top articles in Nanomedicine’s 2019 and 2020 issues by citationsTable Footnote†
.
Table 3. Top articles in Nanomedicine’s 2020 issues by Altmetric scoreTable Footnote†
.
Nikaeen G, Abbaszadeh S, Yousefinejad S. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses. Nanomedicine (Lond.) 15(15), 1501–1512 (2020). Uskoković V. Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic? Nanomedicine (Lond.) 15(17), 1719–1734 (2020). Abd Ellah NH, Gad SF, Muhammad K, Batiha GE, Hetta FH. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine (Lond.) 15(21), 2085–2102 (2020). Rinde M, Kupferschmidt N, Iqbal MN et al. Mesoporous silica with precisely controlled pores reduces food efficiency and suppresses weight gain in mice. Nanomedicine (Lond.) 15(2), 131–144 (2020). Singh D, Dilnawaz F, Sahoo SK. Challenges of moving theranostic nanomedicine into the clinic. Nanomedicine (Lond.) 15(2), 111–114 (2020). Yuexuan Y, Daocheng W. Research shortcomings of fluorescent nanothermometers in biological and medical fields. Nanomedicine (Lond.) 15(8), 735–738 (2020). Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine (Lond.) 14(1), 93–126 (2019). Bari E, Perteghella S, Catenacci L et al. Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy. Nanomedicine (Lond.) 14(6), 753–765 (2019). He L, Liu Y, Lau J et al. Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy. Nanomedicine (Lond.) 14(10), 1343–1365 (2019). Wen R, Umeano AC, Kou Y, Xu J, Farooqi AA. Nanoparticle systems for cancer vaccine. Nanomedicine (Lond.) 14(5), 627–648 (2019). Harshita Barkat MA, Beg S, Pottoo FH, Ahmad FJ. Nanopaclitaxel therapy: an evidence based review on the battle for next-generation formulation challenges. Nanomedicine (Lond.) 14(10), 1323–1341 (2019). Afzal I, Sarwar HS, Sohail MF et al. Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis. Nanomedicine (Lond.) 14(4), 387–406 (2019). Grillone A, Battaglini M, Moscato S et al. Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment. Nanomedicine (Lond.) 14(6), 727–752 (2019). Mulvihill JJ, Cunnane EM, Ross AM, Duskey JT, Tosi G, Grabrusker AM. Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers. Nanomedicine (Lond.) 15(2), 205–214 (2020). Ulanova M, Polijak A, Wen W et al. Nanoparticles as contrast agents for the diagnosis of Alzheimer’s disease: a systematic review. Nanomedicine (Lond.) 15(7), 725–743 (2020). Garcia-Chica J, Paraiso WKD, Tanabe S et al. An overview of nanomedicines for neuron targeting. Nanomedicine (Lond.) 15(16), 1617–1636 (2020). Luly KM, Choi J, Rui Green JJ, Jackson EM. Safety considerations for nanoparticle gene delivery in pediatric brain tumors. Nanomedicine (Lond.) 15(18), 1805–1815 (2020).